Compare Johnson & Johnson (JNJ) vs PAGSEG Inc (PAGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs PAGSEG Inc — how do they compare? Johnson & Johnson trades at $260.51 (market cap $626.09B), while PAGSEG Inc trades at $8.7 (market cap $2.48B). The key difference: Johnson & Johnson is far larger — about 252.5× PAGSEG Inc's market cap, and PAGSEG Inc pays the higher dividend (11.7%). Which is the better fit depends on your goals.
| JNJ | PAGS | |
|---|---|---|
Market Cap | $626.09B | $2.48B |
Volume | 6,156,228 | — |
Sector | Health | Technology |
52-Week High | $267.24 | $12.00 |
52-Week Low | $172.78 | $8.38 |
Enterprise Value | $654.37B | $10.22B |
Dividend Yield | 2.06% | 11.7% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.
Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.
PAGS trades at $8.72, down 3.96% today, with mixed technical signals showing bearish moving averages but neutral oscillators. The stock presents compelling value with a P/E of 6.17 and P/B of 0.87, supported by strong profitability metrics including 53.05% gross margin and 14.52% ROE. Recent Q2 2026 earnings beat expectations with EPS of $0.41 versus $0.389 expected, while Q1 2026 showed a slight miss.
Analyst consensus remains bullish with 62.5% buy ratings and a $11.45 price target, suggesting 31% upside potential. Key risks include competitive pressures in Brazil's digital banking sector and macroeconomic sensitivity to interest rate cycles. The company maintains solid cash flow generation with $7.56B operating cash flow in 2025, supporting ongoing business expansion.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About PAGSEG Inc
PagSeguro Digital Ltd. is a leading provider of financial technology solutions in Brazil, primarily focused on e-commerce, face-to-face transactions, and financial services. The company's main offerings include PagBank, a digital banking platform, and PagSeguro, a suite of payment processing solutions that includes point-of-sale devices and online payment gateways. PAGS targets micro-merchants, small and medium-sized enterprises (SMEs), and consumers, aiming to democratize access to financial services in the country.
Read more on PAGS →
